Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Physician recommendations trump patient preferences in prostate cancer treatment decisions.Med Decis Making. 2017; 37: 56-69https://doi.org/10.1177/0272989X16662841
- How expert physicians would wish to be treated if they had genitourinary cancer.J Clin Oncol. 1988; 6: 1736-1745https://doi.org/10.1200/JCO.19184.108.40.2066
- Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. Article.JAMA. 2000; 283: 3217https://doi.org/10.1001/jama.283.24.3217
- Radiotherapy after radical prostatectomy: treatment recommendations differ between urologists and radiation oncologists. Article.PLoS ONE. 2013; 8: 1-1https://doi.org/10.1371/journal.pone.0079773
- Specialty bias in treatment recommendations and quality of life among radiation oncologists and urologists for localized prostate cancer. Article.Prostate Cancer Prostatic Dis. 2014; 17: 163-169https://doi.org/10.1038/pcan.2014.3
- Differences in practice patterns between urologists and radiation oncologists in the management of localized prostate cancer: a cross-sectional survey. Article.World J Urol. 2015; 33: 1741-1747https://doi.org/10.1007/s00345-015-1543-2
- 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer.N Engl J Med. 2016; 375: 1415-1424https://doi.org/10.1056/NEJMoa1606220
- Preparing patients with early stage prostate cancer to participate in clinical appointments using a shared decision making training video.Med Decis Making. 2021; 42: 364-374https://doi.org/10.1177/0272989X211028563
- The Physician Recommendation Coding System (PhyReCS): a reliable and valid method to quantify the strength of physician recommendations during clinical encounters.Med Decis Making. 2017; 37: 46-55
- Patient reflections on decision making for laryngeal cancer treatment.Otolaryngol Head Neck Surg. 2017; 156: 299-304
Financial Disclosure: The authors have no disclosures.
Funding Support: This work was supported by the National Institutes of Health, National Cancer Institute [P50 CA101451-10] to Drs. Fagerlin and Ubel for the data from the parent clinical trial. Dr. Delaney's research effort was supported in part by the National Institutes of Health under Ruth L. Kirschstein National Research Service Award [T32HL007576] from the National Heart, Lung, and Blood Institute.